Clinical Characteristics Correlate With Outcomes of Immunotherapy in Advanced Non-Small Cell Lung Cancer

Considering the existing indicators are not sufficient to predict the patient's response to immune checkpoint inhibitors (ICIs), we conducted this study to evaluate the efficacy and safety of ICIs in advanced non-small cell lung cancer (NSCLC) patients, and to determine prognostic factors of IC...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lan, Li, Li, Zhou, Yingxu, Yang, Zhaoyang, Wang, Meng, Gao, Yina, Yang, Yang, Yang, Fang, Liu, Bao, Hong, Xuan, Chen, Gongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646175/
https://www.ncbi.nlm.nih.gov/pubmed/33193876
http://dx.doi.org/10.7150/jca.49213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646175/
https://www.ncbi.nlm.nih.gov/pubmed/33193876
http://dx.doi.org/10.7150/jca.49213

Ejemplares similares